| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/23/2002 | WO2001074344A3 Small organic molecule regulators of cell proliferation |
| 05/23/2002 | WO2001072837A3 Methods of modulating drug clearance mechanisms by altering sxr activity |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/23/2002 | WO2001072294A3 Method of treating hepatitis delta viral infection |
| 05/23/2002 | WO2001070212A3 Method and composition for preventing or reducing the symptoms of menopause |
| 05/23/2002 | WO2001066097A3 Active substance directed against microbes of the genus pseudomonas |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives |
| 05/23/2002 | WO2001049316A3 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
| 05/23/2002 | WO2001044206A9 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 05/23/2002 | WO2001042179A9 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2001040271A9 Cancer associated antigens and uses therefor |
| 05/23/2002 | WO2001035945A3 Use of prostaglandin a2 for the treatment and prophylaxis of priapism |
| 05/23/2002 | WO2001035941A3 Novel composition based on a thiazolidinedione and metformin and use |
| 05/23/2002 | WO2001030330A3 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 05/23/2002 | WO2001022953A3 Use of retigabin for treating neuropathic pain |
| 05/23/2002 | WO2001001975A3 Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents |
| 05/23/2002 | WO2000071121A9 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/23/2002 | WO2000063204A3 Substituted azoles |
| 05/23/2002 | WO2000054765A8 Method of treating eating disorders |
| 05/23/2002 | US20020062488 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 05/23/2002 | US20020062102 Electrodes and method for manufacturing electrodes for electrically assisted drug delivery |
| 05/23/2002 | US20020062044 Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules |
| 05/23/2002 | US20020062031 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 05/23/2002 | US20020062024 Hetero-tetrahydroquinolines |
| 05/23/2002 | US20020062023 Palau'amine; treatment of tumors, fungal infections and immunosuppressive affections. |
| 05/23/2002 | US20020062022 Processes for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indoles and derivatives |
| 05/23/2002 | US20020062019 Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 05/23/2002 | US20020061932 Pharmaceutical composition |
| 05/23/2002 | US20020061931 <.5% of a corresponding lactam and > 20 ppm of an anion of a mineral acid, and after one year of storage at 25 degrees C. and 60% humidity conversion to the lactam doesn't exceed .2% |
| 05/23/2002 | US20020061927 Bis-naphthyl urea derivatives |
| 05/23/2002 | US20020061926 Pharmaceutical composition and method of using the same |
| 05/23/2002 | US20020061925 Method for the preparation of citalopram |
| 05/23/2002 | US20020061924 Antiischemic agents, improving deformability of erythrocyte membrane and peripheral circulation |
| 05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
| 05/23/2002 | US20020061922 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| 05/23/2002 | US20020061920 Selected fused pyrrolocarbazoles |
| 05/23/2002 | US20020061919 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one |
| 05/23/2002 | US20020061918 Benzyl isooxazole and benzyl pyrazole derivatives as aldose reductase and cyclooxygenase-2 inhibitors |
| 05/23/2002 | US20020061917 Efficient process for the preparation of a factor Xa inhibitor |
| 05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 05/23/2002 | US20020061915 Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061913 Bicyclic amine derivatives |
| 05/23/2002 | US20020061912 Piperidinylmethyloxazolidinone derivative |
| 05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
| 05/23/2002 | US20020061910 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 05/23/2002 | US20020061909 Vitronectin receptor antagonist pharmaceuticals |
| 05/23/2002 | US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides |
| 05/23/2002 | US20020061907 Macrolide compound, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener; topical for skin disorders |
| 05/23/2002 | US20020061906 Aerosol compositions |
| 05/23/2002 | US20020061905 Ethers of 7-desmethylrapamycin |
| 05/23/2002 | US20020061904 Hydroxyesters of 7-desmethylrapamycin |
| 05/23/2002 | US20020061902 For allergic and/or inflammatory condition of the skin or upper airway passages; administering antihistamine |
| 05/23/2002 | US20020061899 Administering to patient with drug-induced peripheral neuropathy an effective quantity of a purine derivative or analogue, a tetrahydroindolone derivative or analogue, or a pyrimidine derivative or analogue |
| 05/23/2002 | US20020061898 Inhibitors of nucleoside metabolism |
| 05/23/2002 | US20020061896 Imidazopyrimidine nucleoside analogues with anti-HIV activity |
| 05/23/2002 | US20020061895 6-fluoro-1,4-dihydro-7-[4-(2-hydroxyiminoethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions |
| 05/23/2002 | US20020061894 Treatment of Mycobacteria infection by administering (S)-lomefloxacin or a pharmaceutically acceptable salt thereof free of its (R)-stereoisomer |
| 05/23/2002 | US20020061893 Using gemifloxacin compound |
| 05/23/2002 | US20020061892 Antiviral azaindole derivatives |
| 05/23/2002 | US20020061891 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 05/23/2002 | US20020061890 Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives |
| 05/23/2002 | US20020061888 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 05/23/2002 | US20020061884 And from 50 to 99% by weight of a vegetable oil selected from olive oil, peanut oil, soybean oil, corn oil, safflower oil, sunflower oil, canola oil, or walnut oil |
| 05/23/2002 | US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/23/2002 | US20020061879 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 05/23/2002 | US20020061878 Diazacycloalkanedione derivatives |
| 05/23/2002 | US20020061877 Substituted cyclic amine metalloprotease inhibitors |
| 05/23/2002 | US20020061875 Anti-estrogen plus progestin containing oral contraceptives |
| 05/23/2002 | US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome |
| 05/23/2002 | US20020061873 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component, and a surfactant |
| 05/23/2002 | US20020061872 For oral administration or embedded or otherwise attached to medical devices for blood collection and/or treatment |
| 05/23/2002 | US20020061871 Photochemotherapeutic compositions |
| 05/23/2002 | US20020061870 Dosage forms useful for modifying conditions and functions associated with hearing loss and/or tinnitus |
| 05/23/2002 | US20020061869 Free insulin testosterone test |
| 05/23/2002 | US20020061868 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 05/23/2002 | US20020061867 Inhibiting the conversion of non-neoplastic ovarian epithelial cells to neoplastic cells by administering 1,25-dihydroxyvitamin D3 and a hormone product such as progestin to women with high risk of developing ovarian cancer |
| 05/23/2002 | US20020061866 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor |
| 05/23/2002 | US20020061865 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders |
| 05/23/2002 | US20020061864 Antiseptic spermicidal composition and means for its application |
| 05/23/2002 | US20020061863 Consisting of 4-thiouridine, isomaltitol, and uridine; also for problems in hemostasis related to platelet function or inflammation associated with bacterial infection |
| 05/23/2002 | US20020061860 Antisense oligonucleotide inhibition of specific histone deacetylase isoforms |
| 05/23/2002 | US20020061859 Antisense oligonucleotides and antibodies which inhibit its expression or biological activity |
| 05/23/2002 | US20020061858 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives |
| 05/23/2002 | US20020061857 9-amino-3-oxo erythromycin derivatives |
| 05/23/2002 | US20020061856 Macrolide antibiotics effective against infections caused by certain gram-positive and gram-negative bacteria as well as protozoa in a mammal, bird or fish; tri or tetracyclic erythromycin derivatives |
| 05/23/2002 | US20020061855 Method of treating acne vulgaris using avermectin compound |
| 05/23/2002 | US20020061854 Hydroxymatairesinol, a geometric isomer or a stereoisomer or salt in combination with carrier, useful as additive to a food product, present either sole lignan or single component of lignan |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection |
| 05/23/2002 | US20020061844 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061837 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 05/23/2002 | US20020061836 Modifying drug pharmacokinetics by altering the activity of steroid xenobiotic receptor(SXR) on expression levels of CYP2C8 or MDR1 cytochrome |
| 05/23/2002 | US20020061835 In vivo delivery methods and compositions |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |